Effect of pulse on iontophoretic delivery of desmopressin acetate in rats

Biological and Pharmaceutical Bulletin

Volumn 19, Issue 5, 1996, Pages 738-740

  Nakakura, Masashi ^a   Kato, Yasuki ^a   Hayakawa, Eiji ^a   Ito, Kunio ^a   Kuroda, Tokuyuki ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

desmopressin acetate; iontophoresis; pulse current; skin permeability

Indexed keywords

DESMOPRESSIN ACETATE;

ANIMAL MODEL; ANTIDIURESIS; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIABETES INSIPIDUS; DIRECT CURRENT; DOSE RESPONSE; DRUG ABSORPTION; INTRAVENOUS DRUG ADMINISTRATION; IONTOPHORESIS; MALE; NONHUMAN; OSMOTIC PRESSURE; RAT;

EID: 0029903085     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.19.738     Document Type: Article

References (25)

1. Banerjee P. S., Ritschel W. A., Int. J. Pharmaceut., 49, 189 (1989).
2. Tojo K., Int. J. Pharmaceut., 43, 201 (1988).
3. Ho H., Chien Y. W., Drug Dev. Ind Pharm., 19, 295 (1993).
4. Campbell R. L., Bruce R. D., Toxicol. Appl. Pharmacol., 59, 555 (1981).
5. Banerjee P. S., Ritschel W. A., Int. J. Pharmaceut., 49, 199 (1989).
6. Lelawongs P., Liu J.-C., Chien Y. W., Int. J. Pharmaceut., 56, 13 (1989).
7. Pikal M. J., Adv. Drug Deliv. Rev., 9, 201 (1992).
8. Morimoto K., Iwakura Y., Miyazaki M., Nakatani E., Int. J. Pharmaceut., 81, 119 (1992).
9. Srinivasan V., Higuchi W. I., Sims S. M., Ghanem A. H., Behl C. R., J. Pharm. Sci., 78, 370 (1989).
10. Sims S. M., Higuchi W. I., Srinivasan V., Int. J. Pharmaceut., 69, 109 (1991).
11. Delgado-Charro M. B., Guy R. H., Pharm. Res., 11, 929 (1994).
12. DeNuzzio J. D., Berner B., J. Controlled Release, 11, 105 (1990).
13. Bagniefski T., Burnette R. R., J. Controlled Release, 11, 113 (1990).
14. Liu J.-C., Sun Y., Siddiqui O., Chien Y. W., Shi W.-M., Li J., Int. J. Pharmaceut., 44, 197 (1988).
15. Sudeji K., Kawasaki M., Inada H., Katayama K., Kakemi M., Koizumi T., Yakugakuzasshi, 109, 771 (1989).
16. Numajiri S., Sakurai H., Sugibayasi K., Morimoto Y., Omiya H., Takenaka H., Akiyama N., J. Pharm. Pharmacol., 45, 610 (1993).
17. Nakakura M., Terajima M., Kato Y., Hayakawa E., Ito K., Kuroda T., J. Drug Targeting, 2, 487 (1995).
18. Harris A. S., Hedner P., Vilhardt H., J. Pharm. Pharmacol., 39, 932 (1987).
19. Fjellestad-Paulsen A., Tubiana-Rufi N., Harris A., Czernichow P., Acta Endocrinologica, 115, 307 (1987).
20. Smolen V. F., Weigand W. A., J. Pharmacokinet. Biopharm., 1, 329 (1973).
21. Smolen V. F., J. Pharmacokinet. Biopharm., 4, 337 (1976).
22. Rado J. P., Marosi J., Fischer J., Tako J., Kiss N., Endokrinologie, 66, 184 (1975).
23. Williams T. D. M., Dunger D. B., Lyon C. C., Lewis R. J., Taylon F., Lightman S. L., J. Clin. Endocrinol. Metab., 63, 129 (1986).
24. Craane-van Hinsberg W. H. M., Bax L., Flinterman N. H. M., Verhoef J., Junginger H. E., Bodde H. E., Pharm. Res., 11, 1296 (1994).
25. Riviere J. E., Sage B., Williams P. L., J. Pharm. Sci., 80, 615 (1991).